Novolog (Pharm-Up 1966) Ltd

TASE:NVLG Stock Report

Market Cap: ₪878.9m

Novolog (Pharm-Up 1966) Balance Sheet Health

Financial Health criteria checks 5/6

Novolog (Pharm-Up 1966) has a total shareholder equity of ₪393.1M and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪3.2B and ₪2.8B respectively. Novolog (Pharm-Up 1966)'s EBIT is ₪69.1M making its interest coverage ratio 4.4. It has cash and short-term investments of ₪239.9M.

Key information

0%

Debt to equity ratio

₪0

Debt

Interest coverage ratio4.4x
Cash₪239.95m
Equity₪393.14m
Total liabilities₪2.77b
Total assets₪3.16b

Recent financial health updates

No updates

Recent updates

Estimating The Fair Value Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Nov 05
Estimating The Fair Value Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Be Wary Of Novolog (Pharm-Up 1966) (TLV:NVLG) And Its Returns On Capital

Jul 25
Be Wary Of Novolog (Pharm-Up 1966) (TLV:NVLG) And Its Returns On Capital

I Ran A Stock Scan For Earnings Growth And Novolog (Pharm-Up 1966) (TLV:NVLG) Passed With Ease

May 07
I Ran A Stock Scan For Earnings Growth And Novolog (Pharm-Up 1966) (TLV:NVLG) Passed With Ease

Read This Before Buying Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) For Its Dividend

Apr 14
Read This Before Buying Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) For Its Dividend

Novolog (Pharm-Up 1966)'s (TLV:NVLG) Earnings Are Of Questionable Quality

Mar 24
Novolog (Pharm-Up 1966)'s (TLV:NVLG) Earnings Are Of Questionable Quality

Novolog (Pharm-Up 1966) Ltd's (TLV:NVLG) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 09
Novolog (Pharm-Up 1966) Ltd's (TLV:NVLG) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

How Much Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) Do Insiders Own?

Feb 15
How Much Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) Do Insiders Own?

Update: Novolog (Pharm-Up 1966) (TLV:NVLG) Stock Gained 88% In The Last Three Years

Jan 25
Update: Novolog (Pharm-Up 1966) (TLV:NVLG) Stock Gained 88% In The Last Three Years

How Much Is Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) CEO Getting Paid?

Dec 29
How Much Is Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) CEO Getting Paid?

With EPS Growth And More, Novolog (Pharm-Up 1966) (TLV:NVLG) Is Interesting

Dec 08
With EPS Growth And More, Novolog (Pharm-Up 1966) (TLV:NVLG) Is Interesting

Financial Position Analysis

Short Term Liabilities: NVLG's short term assets (₪2.5B) do not cover its short term liabilities (₪2.6B).

Long Term Liabilities: NVLG's short term assets (₪2.5B) exceed its long term liabilities (₪194.1M).


Debt to Equity History and Analysis

Debt Level: NVLG is debt free.

Reducing Debt: NVLG has no debt compared to 5 years ago when its debt to equity ratio was 0.2%.

Debt Coverage: NVLG has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: NVLG has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies